Djibouti vs South Sudan: Prevalence rate of hypertension in women aged 30-79
Djibouti
35.8
in 2019
South Sudan
36
in 2019
Djibouti rank
115th
South Sudan rank
114th
Prevalence rate of hypertension in women aged 30-79 over time
- Djibouti
- South Sudan
How they compare
South Sudan currently reports 36 against 35.8 in Djibouti, a difference of 0.2.
The two have swapped places 8 times across 30 shared years of data; in 1990 it was South Sudan ahead.
Djibouti ranks 115th and South Sudan ranks 114th of 195 countries.
Across the 3 decades both report, Djibouti averaged higher in 2 and South Sudan in 1.
Head to head by decade
| Decade | Djibouti | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 35.04 | 34.99 | 0.05 | Djibouti |
| 2000s | 36.86 | 36.83 | 0.03 | Djibouti |
| 2010s | 36.9 | 36.95 | 0.05 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Djibouti or South Sudan?
- South Sudan, at 36 against 35.8 in Djibouti as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Djibouti and South Sudan?
- 0.2, with South Sudan ahead.
- How many years of comparable data are there for Djibouti and South Sudan?
- 30 years are reported by both, from 1990 to 2019.
- How do Djibouti and South Sudan rank globally for prevalence rate of hypertension in women aged 30-79?
- Djibouti ranks 115th and South Sudan ranks 114th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.